BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Gernot Fugger, Markus Dold, Lucie Bartova, Alexander Kautzky, Daniel Souery, Julien Mendlewicz, Alessandro Serretti, Joseph Zohar, Stuart Montgomery, Richard Frey, Siegfried Kasper. Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD)European Neuropsychopharmacology 2018; 28(6): 752 doi: 10.1016/j.euroneuro.2018.03.011
2
Thomas RE Barnes, Richard Drake, Carol Paton, Stephen J Cooper, Bill Deakin, I Nicol Ferrier, Catherine J Gregory, Peter M Haddad, Oliver D Howes, Ian Jones, Eileen M Joyce, Shôn Lewis, Anne Lingford-Hughes, James H MacCabe, David Cunningham Owens, Maxine X Patel, Julia MA Sinclair, James M Stone, Peter S Talbot, Rachel Upthegrove, Angelika Wieck, Alison R Yung. Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for PsychopharmacologyJournal of Psychopharmacology 2020; 34(1): 3 doi: 10.1177/0269881119889296
3
Francisco López-Muñoz, Cecilio Álamo, Pilar García-García. Melatonin, Neuroprotective Agents and Antidepressant Therapy2016; : 421 doi: 10.1007/978-81-322-2803-5_28
4
Jari Tiihonen, Antti Tanskanen, Fabian Hoti, Pia Vattulainen, Heidi Taipale, Juha Mehtälä, Markku Lähteenvuo. Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort studyThe Lancet Psychiatry 2017; 4(7): 547 doi: 10.1016/S2215-0366(17)30134-7
5
Jia Liu, Xin Xu, Qiang Luo, Ya Luo, Ying Chen, Su Lui, Min Wu, Hongyan Zhu, Graham J. Kemp, Qiyong Gong. Brain grey matter volume alterations associated with antidepressant response in major depressive disorderScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10676-5
6
Liwei Liao, Zhiguo Wu, David Mellor, Daihui Peng, Chen Zhang, Jingjing Xu, Chenglei Wang, Lvchun Cui, Yiru Fang. Subtypes of treatment-resistant depression determined by a latent class analysis in a Chinese clinical populationJournal of Affective Disorders 2019; 249: 82 doi: 10.1016/j.jad.2019.02.005
7
Dian-Jeng Li, Ping-Tao Tseng, Yen-Wen Chen, Ching-Kuan Wu, Pao-Yen Lin. Significant Treatment Effect of Bupropion in Patients With Bipolar Disorder but Similar Phase-Shifting Rate as Other AntidepressantsMedicine 2016; 95(13): e3165 doi: 10.1097/MD.0000000000003165
8
Julio Bobes, Jerónimo Saiz-Ruiz, Víctor Pérez. Barriers to complete recovery of major depression: Cross-sectional, multi-centre study on clinical practice. RECORD studyRevista de Psiquiatría y Salud Mental (English Edition) 2019; 12(3): 141 doi: 10.1016/j.rpsmen.2018.10.002
9
Zuleide M. Ignácio, Gislaine Z. Réus, Helena M. Abelaira, Airam B. de Moura, Thays G. de Souza, Danyela Matos, Mariana P. Goldim, Khiany Mathias, Leandro Garbossa, Fabricia Petronilho, João Quevedo. Acute and chronic treatment with quetiapine induces antidepressant-like behavior and exerts antioxidant effects in the rat brainMetabolic Brain Disease 2017; 32(4): 1195 doi: 10.1007/s11011-017-0028-y
10
Lucia Carboni, Francesca Pischedda, Giovanni Piccoli, Mario Lauria, Laura Musazzi, Maurizio Popoli, Aleksander A. Mathé, Enrico Domenici. Depression-Associated Gene Negr1-Fgfr2 Pathway Is Altered by Antidepressant TreatmentCells 2020; 9(8): 1818 doi: 10.3390/cells9081818
11
Jasmina Mallet, Philip Gorwood, Yann Le Strat, Caroline Dubertret. Major Depressive Disorder (MDD) and Schizophrenia– Addressing Unmet Needs With Partial Agonists at the D2 Receptor: A ReviewInternational Journal of Neuropsychopharmacology 2019; 22(10): 651 doi: 10.1093/ijnp/pyz043
12
Marco Solmi, Nicola Veronese, Leonardo Zaninotto, Marc L. M. van der Loos, Keming Gao, Ayal Schaffer, Catherine Reis, Claus Normann, Ion-George Anghelescu, Christoph U. Correll. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trialsCNS Spectrums 2016; 21(5): 403 doi: 10.1017/S1092852916000523
13
Yanbo Zhang, Xiaoying Bi, Olubunmi Adebiyi, Junhui Wang, Ali Mooshekhian, Jacob Cohen, Zelan Wei, Fei Wang, Xin-Min Li. Venlafaxine Improves the Cognitive Impairment and Depression-Like Behaviors in a Cuprizone Mouse Model by Alleviating Demyelination and Neuroinflammation in the BrainFrontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00332
14
Rodolfo Savica, Brandon R. Grossardt, James H. Bower, J. Eric Ahlskog, Michelle M. Mielke, Walter A. Rocca. Incidence and time trends of drug-induced parkinsonism: A 30-year population-based studyMovement Disorders 2017; 32(2): 227 doi: 10.1002/mds.26839
15
Jing Sun, Fangyan Wang, Guangliang Hong, Mengqi Pang, Hailing Xu, Haixiao Li, Feng Tian, Renchi Fang, Ye Yao, Jiaming Liu. Antidepressant-like effects of sodium butyrate and its possible mechanisms of action in mice exposed to chronic unpredictable mild stressNeuroscience Letters 2016; 618: 159 doi: 10.1016/j.neulet.2016.03.003
16
Kunitoshi Kamijima, Moriyoshi Yasuda, Kayo Yamamura, Yasuhiko Fukuta. Real-world effectiveness and safety of aripiprazole augmentation therapy in patients with major depressive disorderCurrent Medical Research and Opinion 2018; 34(12): 2105 doi: 10.1080/03007995.2018.1519317
17
měli bychom zhodnotit diagnostické aspekty, hlavně komorbiditu a adekvátnost dosavadní léčby včetně adherence.. Pharmacoresistant depression - what is the next step?Psychiatrie pro praxi 2016; 17(3): 92 doi: 10.36290/psy.2016.025
18
Horacio A. Capote, Michelle Rainka, Erica S. Westphal, Jonathan Beecher, Francis M. Gengo. Ropinirole in Bipolar Disorder: Rate of Manic Switching and Change in Disease SeverityPerspectives in Psychiatric Care 2018; 54(2): 100 doi: 10.1111/ppc.12205
19
Zuleide Maria Ignácio, Ana Valquíria Calixto, Ritele Hernandez da Silva, João Quevedo, Gislaine Zilli Réus. The use of quetiapine in the treatment of major depressive disorder: Evidence from clinical and experimental studiesNeuroscience & Biobehavioral Reviews 2018; 86: 36 doi: 10.1016/j.neubiorev.2017.12.012
20
Antonio Tundo, Laura Musetti, Rocco de Filippis, Claudia Del Grande, Valentina Falaschi, Luca Proietti, Liliana Dell'Osso. Is there a relationship between depression with anxious distress DSM-5 specifier and bipolarity? A multicenter cohort study on patients with unipolar, bipolar I and II disordersJournal of Affective Disorders 2019; 245: 819 doi: 10.1016/j.jad.2018.11.024
21
Jon E. Grant, Sarah A. Redden, Eric W. Leppink. Double-blind switch study of vilazodone in the treatment of major depressive disorderInternational Clinical Psychopharmacology 2017; 32(3): 121 doi: 10.1097/YIC.0000000000000166
22
Liangcai Gao, Xinnan Liu, Li Yu, Junlin Wu, Mingchu Xu, Yusi Liu. Folic acid exerts antidepressant effects by upregulating brain-derived neurotrophic factor and glutamate receptor 1 expression in brainNeuroReport 2017; 28(16): 1078 doi: 10.1097/WNR.0000000000000887
23
Nobue Kitanaka, Frank Scott Hall, George Richard Uhl, Junichi Kitanaka. Lithium Pharmacology and a Potential Role of Lithium on Methamphetamine Abuse and DependenceCurrent Drug Research Reviews 2019; 11(2): 85 doi: 10.2174/2589977511666190620141824
24
Denis Sarrouilhe, Marc Mesnil, Catherine Dejean . Targeting Gap Junctions: New Insights into the Treatment of Major Depressive DisorderCurrent Medicinal Chemistry 2019; 26(20): 3775 doi: 10.2174/0929867325666180327103530
25
Elise Morlet, Jean-François Costemale-Lacoste, Emmanuel Poulet, Kibby McMahon, Nicolas Hoertel, Frédéric Limosin, J Adès, C Alezrah, I Amado, G Amar, O Andréi, D Arbault, G Archambault, G Aurifeuille, S Barrière, C Béra-Potelle, Y Blumenstock, H Bardou, M Bareil-Guérin, P Barrau, C Barrouillet, E Baup, N Bazin, B Beaufils, J Ben Ayed, M Benoit, K Benyacoub, T Bichet, F Blanadet, O Blanc, J Blanc-Comiti, D Boussiron, AM Bouysse, A Brochard, O Brochart, B Bucheron, M Cabot, V Camus, JM Chabannes, V Charlot, T Charpeaud, C Clad-Mor, C Combes, M Comisu, B Cordier, F Costi, JP Courcelles, M Creixell, H Cuche, C Cuervo-Lombard, A Dammak, D Da Rin, JB Denis, H Denizot, A Deperthuis, E Diers, S Dirami, D Donneau, P Dreano, C Dubertret, E Duprat, D Duthoit, C Fernandez, P Fonfrede, N Freitas, P Gasnier, J Gauillard, F Getten, F Gierski, F Godart, R Gourevitch, A Grassin Delyle, J Gremion, H Gres, V Griner, C Guerin-Langlois, C Guggiari, O Guillin, H Hadaoui, E Haffen, C Hanon, S Haouzir, C Hazif-Thomas, A Heron, B Hubsch, I Jalenques, D Januel, A Kaladjian, JF Karnycheff, O Kebir, MO Krebs, C Lajugie, M Leboyer, P Legrand, M Lejoyeux, V Lemaire, E Leroy, D Levy-Chavagnat, A Leydier, C Liling, PM Llorca, P Loeffel, P Louville, S Lucas Navarro, N Mages, M Mahi, O Maillet, A Manetti, C Martelli, P Martin, M Masson, I Maurs-Ferrer, J Mauvieux, S Mazmanian, E Mechin, L Mekaoui, M Meniai, A Metton, A Mihoubi, M Miron, G Mora, V Niro Adès, P Nubukpo, C Omnes, S Papin, P Paris, C Passerieux, J Pellerin, J Perlbarg, S Perron, A Petit, F Petitjean, C Portefaix, D Pringuey, A Radtchenko, H Rahiou, D Raucher-Chéné, A Rauzy, L Reinheimer, M Renard, M René, CE Rengade, P Reynaud, D Robin, C Rodrigues, A Rollet, F Rondepierre, B Rousselot, S Rubingher, G Saba, JP Salvarelli, JC Samuelian, C Scemama-Ammar, F Schurhoff, JP Schuster, D Sechter, B Segalas, T Seguret, AS Seigneurie, A Semmak, F Slama, S Taisne, M Taleb, JL Terra, D Thefenne, E Tran, R Tourtauchaux, MN Vacheron, P Vandel, V Vanhoucke, E Venet, H Verdoux, A Viala, G Vidon, M Vitre, JL Vurpas, C Wagermez, M Walter, L Yon, X. Zendjidjian. Psychiatric and physical outcomes of long-term use of lithium in older adults with bipolar disorder and major depressive disorder: A cross-sectional multicenter studyJournal of Affective Disorders 2019; 259: 210 doi: 10.1016/j.jad.2019.08.056
26
Francesco Angelucci, Bart A Ellenbroek, Aram El Khoury, Aleksander A. Mathé. CGRP in a gene–environment interaction model for depression: effects of antidepressant treatmentActa Neuropsychiatrica 2019; 31(2): 93 doi: 10.1017/neu.2018.31
27
Dian-Jeng Li, Fu-Chiang Wang, Che-Sheng Chu, Tien-Yu Chen, Chia-Hung Tang, Wei-Cheng Yang, Philip Chik-keung Chow, Ching-Kuan Wu, Ping-Tao Tseng, Pao-Yen Lin. Significant treatment effect of add-on ketamine anesthesia in electroconvulsive therapy in depressive patients: A meta-analysisEuropean Neuropsychopharmacology 2017; 27(1): 29 doi: 10.1016/j.euroneuro.2016.11.008
28
Julio Bobes, Jerónimo Saiz-Ruiz, Víctor Pérez. Barreras para la recuperación completa en la depresión mayor: estudio transversal multicéntrico en la práctica clínica. Estudio RECORDRevista de Psiquiatría y Salud Mental 2019; 12(3): 141 doi: 10.1016/j.rpsm.2018.10.002
29
A. Tundo, R. Filippis, F. De Crescenzo. Pramipexole in the treatment of unipolar and bipolar depression. A systematic review and meta‐analysisActa Psychiatrica Scandinavica 2019; 140(2): 116 doi: 10.1111/acps.13055
30
Marlene P. Freeman, George I. Papakostas, Bettina Hoeppner, Erica Mazzone, Heidi Judge, Cristina Cusin, Sanjay Mathew, Gerard Sanacora, Dan Iosifescu, Charles DeBattista, Madhukar H. Trivedi, Maurizio Fava. Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depressionJournal of Psychiatric Research 2019; 110: 166 doi: 10.1016/j.jpsychires.2019.01.010
31
Mohammed T. Abou-Saleh, Bruno Müller-Oerlinghausen, Alec J. Coppen. Lithium in the episode and suicide prophylaxis and in augmenting strategies in patients with unipolar depressionInternational Journal of Bipolar Disorders 2017; 5(1) doi: 10.1186/s40345-017-0080-x